VA expands precision medicine through pharmacogenomics

(Source – news.va.gov)

In recent years, VA has become a national leader in precision medicine, using pharmacogenomics (PGx) to personalize prescriptions and improve outcomes for Veterans. PGx testing analyzes how a Veteran’s genes affect their response to medications, reducing trial-and-error prescribing and preventing dangerous side effects. Continue reading here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.